1. Home
  2. ODP vs ATXS Comparison

ODP vs ATXS Comparison

Compare ODP & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ODP
  • ATXS
  • Stock Information
  • Founded
  • ODP 1986
  • ATXS 2008
  • Country
  • ODP United States
  • ATXS United States
  • Employees
  • ODP N/A
  • ATXS N/A
  • Industry
  • ODP Other Specialty Stores
  • ATXS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ODP Consumer Discretionary
  • ATXS Health Care
  • Exchange
  • ODP Nasdaq
  • ATXS Nasdaq
  • Market Cap
  • ODP 473.2M
  • ATXS 401.2M
  • IPO Year
  • ODP N/A
  • ATXS 2015
  • Fundamental
  • Price
  • ODP $17.18
  • ATXS $4.23
  • Analyst Decision
  • ODP Hold
  • ATXS Strong Buy
  • Analyst Count
  • ODP 1
  • ATXS 6
  • Target Price
  • ODP $28.00
  • ATXS $30.00
  • AVG Volume (30 Days)
  • ODP 588.6K
  • ATXS 498.3K
  • Earning Date
  • ODP 05-07-2025
  • ATXS 05-20-2025
  • Dividend Yield
  • ODP N/A
  • ATXS N/A
  • EPS Growth
  • ODP N/A
  • ATXS N/A
  • EPS
  • ODP N/A
  • ATXS N/A
  • Revenue
  • ODP $6,820,000,000.00
  • ATXS N/A
  • Revenue This Year
  • ODP N/A
  • ATXS N/A
  • Revenue Next Year
  • ODP N/A
  • ATXS N/A
  • P/E Ratio
  • ODP N/A
  • ATXS N/A
  • Revenue Growth
  • ODP N/A
  • ATXS N/A
  • 52 Week Low
  • ODP $11.85
  • ATXS $3.56
  • 52 Week High
  • ODP $52.60
  • ATXS $12.92
  • Technical
  • Relative Strength Index (RSI)
  • ODP 69.54
  • ATXS 36.98
  • Support Level
  • ODP $13.57
  • ATXS $5.01
  • Resistance Level
  • ODP $18.29
  • ATXS $5.47
  • Average True Range (ATR)
  • ODP 1.06
  • ATXS 0.39
  • MACD
  • ODP 0.45
  • ATXS -0.01
  • Stochastic Oscillator
  • ODP 81.44
  • ATXS 7.81

About ODP The ODP Corporation

The ODP Corp operates an integrated B2B distribution platform with divisions focusing on various sectors: ODP Business Solutions serves small to enterprise-level companies with office supplies, technology, furniture, and services. Office Depot Division caters to retail consumers and small businesses through retail locations and eCommerce platforms, offering office supplies, technology, and business services. Veyer Division specializes in supply chain, distribution, and procurement services for both internal and third-party customers, with a focus on global operations. Varis Division offers a tech-enabled B2B indirect procurement marketplace, providing a seamless buying experience and advanced spend management tools. Revenue primarily stems from the Veyer division.

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

Share on Social Networks: